Chimeric Therapeutics Limited
CHMMF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$10,430 | -$12,530 | -$25,917 | -$15,898 |
| Dep. & Amort. | $1,032 | $0 | $965 | $950 |
| Deferred Tax | $0 | $0 | -$1,506 | -$7,379 |
| Stock-Based Comp. | $1,086 | $0 | $3,322 | $3,169 |
| Change in WC | -$214 | $3,579 | $3,848 | -$2,212 |
| Other Non-Cash | $1,251 | $1,413 | $2,972 | $8,218 |
| Operating Cash Flow | -$7,276 | -$7,538 | -$16,316 | -$13,153 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$112 | -$538 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | -$40 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $13 |
| Investing Cash Flow | $0 | $0 | -$112 | -$565 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$2,277 | -$2,225 | -$4,087 |
| Stock Issued | $0 | $11,740 | $2,577 | $14,899 |
| Stock Repurch. | $0 | -$1,196 | -$89 | -$1,309 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $10,046 | -$10 | -$10 | $0 |
| Financing Cash Flow | $10,046 | $8,257 | $253 | $9,504 |
| Forex Effect | -$66 | -$29 | $146 | $162 |
| Net Chg. in Cash | $2,704 | $690 | -$16,019 | -$4,029 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3,053 | $2,363 | $18,382 | $22,410 |
| End Cash | $5,757 | $3,053 | $2,363 | $18,382 |
| Free Cash Flow | -$7,276 | -$7,538 | -$16,428 | -$13,691 |